These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 380800

  • 1. Phase I study of succinylated acinetobacter L-glutaminase-L-asparaginase.
    Holcenberg JS, Camitta BM, Borella LD, Ring BJ.
    Cancer Treat Rep; 1979 Jun; 63(6):1025-30. PubMed ID: 380800
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
    Warrell RP, Arlin ZA, Gee TS, Chou TC, Roberts J, Young CW.
    Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
    [Abstract] [Full Text] [Related]

  • 4. Human pharmacology and toxicology of succinylated Acinetobacter glutaminase-asparaginase.
    Holcenberg JS, Borella LD, Camitta BM, Ring BJ.
    Cancer Res; 1979 Aug; 39(8):3145-51. PubMed ID: 455299
    [No Abstract] [Full Text] [Related]

  • 5. Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults.
    Warrell RP, Chou TC, Gordon C, Tan C, Roberts J, Sternberg SS, Philips FS, Young CW.
    Cancer Res; 1980 Dec; 40(12):4546-51. PubMed ID: 7438089
    [Abstract] [Full Text] [Related]

  • 6. Enzyme therapy of cancer, future studies.
    Holcenberg JS.
    Cancer Treat Rep; 1981 Dec; 65 Suppl 4():61-5. PubMed ID: 7346158
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Amino acid utilization and urine protein excretion in children treated with succinylated Acinetobacter glutaminase-asparaginase.
    Kien CL, Holcenberg JS.
    Cancer Res; 1981 Jun; 41(6):2056-62. PubMed ID: 7016307
    [Abstract] [Full Text] [Related]

  • 9. Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy.
    Miller HK, Salser JS, Balis ME.
    Cancer Res; 1969 Jan; 29(1):183-7. PubMed ID: 5763976
    [No Abstract] [Full Text] [Related]

  • 10. Enhancement of melphalan therapy with glutaminase:asparaginase.
    Vistica DT, Rabon A, Rabinovitz M.
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
    [Abstract] [Full Text] [Related]

  • 11. Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.
    Abuchowski A, van Es T, Palczuk NC, McCoy JR, Davis FF.
    Cancer Treat Rep; 1979 Jun; 63(6):1127-32. PubMed ID: 466651
    [Abstract] [Full Text] [Related]

  • 12. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N, Traggis D, Das L, Kim BS, Won H, Hann L, Moloney WC, Dohlwitz A.
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract] [Full Text] [Related]

  • 13. [Biological properties of glutamin-(asparagin-)ase from Pseudomonas boreopolis 526].
    Pekhov AA, Zanin VA, Kozlov AM, Iurchenko AIa, Kondrat'eva NA.
    Biull Eksp Biol Med; 1986 Jul; 102(7):71-4. PubMed ID: 3730598
    [Abstract] [Full Text] [Related]

  • 14. L-glutaminase and L-asparaginase by extracorporeal route in acute lymphoblastic leukemia therapy.
    Giordano C, Esposito R, Mazzola G, Vecchio G, Pluvio M, Cirillo D, Capasso GB, Buonanno G.
    Int J Artif Organs; 1981 Sep; 4(5):244-8. PubMed ID: 6947966
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues.
    Holcenberg JS, Tang E, Dolowy WC.
    Cancer Res; 1975 May; 35(5):1320-5. PubMed ID: 1091350
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Kinetic properties and inhibition of Acinetobacter glutaminase-asparaginase.
    Steckel J, Roberts J, Philips FS, Chou TC.
    Biochem Pharmacol; 1983 Mar 15; 32(6):971-7. PubMed ID: 6838661
    [Abstract] [Full Text] [Related]

  • 19. Favorable remission induction rate with twice weekly doses of L-asparaginase.
    Jaffe N, Traggis D, Das L, Frauenberger G, Hann HW, Kim BS, Bishop Y.
    Cancer Res; 1973 Jan 15; 33(1):1-4. PubMed ID: 4565907
    [No Abstract] [Full Text] [Related]

  • 20. [Attempt of treatment of acute lymphoblastic leukemia by L-asparaginase].
    Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schlumberger JR, Hayat M, De Vassal F, Jasmin C, Rosenfeld C.
    Presse Med (1893); 1969 Mar 15; 77(13):461-3. PubMed ID: 5255425
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.